Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients

Volume 25, Issue 4, April 2024, Pages 1391-1409

Norhan Shalaby; Hala F Zaki; Osama A Badary; Sherif Kamal; Mohamed Nagy; Dalia Makhlouf; Amr Elnashar; Enas Elnadi; Sameh A Abdelshafi; Sherif Abouelnaga; Mona M Saber

• View Article
• PDF 1.15 M

Adverse Effects of Vincristine Chemotherapy on Cell Changes in Seminiferous Tubules and Cetrorelix GnRH Antagonist Inhibitory Effects in Mice

Volume 19, Issue 3, March 2018, Pages 683-687

Fatemeh Nikpour; Hamid Tayefi; Daryosh Mohammadnejad; Abolfazl Akbarzadeh

• View Article
• PDF 293.87 K

Efficacy and Safety of First Line Vincristine with Doxorubicin, Bleomycin and Dacarbazine (ABOD) for Hodgkin’s Lymphoma: a Single Institute Experience

Volume 15, Issue 20, December 2014, Pages 8715-8718

• View Article
• PDF 431.15 K